Priority Date: 11.06.12 (GB 20120010226)

GENETICALLY MODIFIED SCHMALLENBERG VIRUS (SBV) FOR USE AS VACCINE

  • Application ID: EP13729797
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Attorney

operating since 1887
1375.81
Headquarter in London and 20 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Specialization

This EP application has the IPC combination A01, A61, and C12. We found, that Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, Vereenigde Octrooibureaux NV (V.O.), Dennemeyer SA and 34 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 11.06.2012 - Priority Date (GB 20120010226)
  • 19.12.2013 - Publication A1 (WO2013186539)
  • 15.04.2015 - Publication A1 (EP2859094)

IPC Classification